Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The great importance of long noncoding RNAs (lncRNAs) has been acknowledged in tumorigenesis gradually. LncRNA LINC01857 is a novel lncRNA and has been reported to promote breast cancer progression. However, the biological roles of LINC01857 in
glioma
are not explored. In the present research, LINC01857 levels were found to be upregulated in
glioma
. In addition, LINC01857 expression is negatively correlated with survival rate in
glioma
patients. Functional investigation revealed that LINC01857 downregulation impaired
glioma
proliferation and invasiveness. Furthermore, LINC01857 knockdown led to repressed growth of
glioma
in vivo. We found that LINC01857 could be a sponge for miR-1281 and inhibits its level to upregulate
TRIM65
expression. What's more, we showed that miR-1281 mimics also attenuated tumor cell proliferation, migration, and invasion. And rescue assays demonstrated that LINC01857 promotes
glioma
progression through modulating miR-1281/
TRIM65
pathway. Collectively, this study first demonstrated that a novel LINC01857/miR-1281/
TRIM65
signaling regulates
glioma
progression.
...
PMID:LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR-1281/TRIM65 axis. 3104 60